This Solicitation opportunity from Government of Canada was posted on September 27, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Doxycycline Hyclate Tablets or Capsules, 100 mg
Closed
W6369-23-A056CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of National DefenceView Agency
NAICS
N/A
Place of Performance
*Ontario (except NCR), CANSet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of National Defence
Contacts1 person available
OfficeN/A
Office AddressN/A
Contacts
Full Description
Show more
Department of National Defence, has a requirement for Doxycycline Hyclate tablets or capsules of 100 mg for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to bacterial biological warfare agents.The period of the Contract is from date of Contract to 31 March 2026 inclusive.Initial Requirement: The Contractor must supply 259,200 tablets or capsules of Doxycycline Hyclate (100 mg) no later than 31 March 2023.Optional Requirements:a) Optional Requirement 1: If exercised, the Contractor must supply up to 259,200 tablets or capsules of Doxycycline (100 mg) no later than 31 March 2024;b) Optional Requirement 2: If exercised, the Contractor must supply up to 259,200 tablets or capsules of Doxycycline (100 mg) no later than 31 March 2025; and c) Optional Requirement 3: If exercised, the Contractor must supply up to 259,200 tablets or capsules of Doxycycline (100 mg) no later than 31 March 2026.